Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Pacific Biosciences of California Inc’s stock clocked out at $1.18, up 3.51% from its previous closing price of $1.14. In other words, the price has increased by $3.51 from its previous closing price. On the day, 8.79 million shares were traded. PACB stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.08.
Ratios:
To gain a deeper understanding of PACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.59 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.31.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.
Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 351465344 and an Enterprise Value of 633968640. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.28 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 4.116 whereas that against EBITDA is -2.541.
Stock Price History:
The Beta on a monthly basis for PACB is 2.04, which has changed by -0.6539589 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $3.85, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is -19.01%, while the 200-Day Moving Average is calculated to be -30.78%.
Shares Statistics:
It appears that PACB traded 11.25M shares on average per day over the past three months and 7554790 shares per day over the past ten days. A total of 294.42M shares are outstanding, with a floating share count of 263.27M. Insiders hold about 11.61% of the company’s shares, while institutions hold 77.62% stake in the company. Shares short for PACB as of 1741910400 were 53410201 with a Short Ratio of 4.75, compared to 1739491200 on 66690554. Therefore, it implies a Short% of Shares Outstanding of 53410201 and a Short% of Float of 20.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
